Documentation of CMV_USA

View the 98 variables sorted by type, module, group, variable name, module/group/name, Level Structure, or in a view summary.

Model Assessment Results

Model Information Number
Total Number of Variables
98
Total Number of State Variables (Level+Smooth+Delay Variables)
29
Total Number of Stocks (Stocks in Level+Smooth+Delay Variables) †
29
Total Number of Macros
0
Function Sensitivity Parameters
0
Variables with Source Information
0
Data Lookup Tables
0
Time Unit
Year
Initial Time
0
Final Time
100
Time Step
0.0078125
Model Is Fully Formulated
Yes
Modeler-Defined Groups
- No -
VPM File Available
- No -

Warnings Number
Undocumented Equations
94
Equations with Embedded Data
43
Equations With Unit Errors
* *
Variables Not in Any View
0
Incompletely Defined Subscripted Variables
0
Nonmonotonic Lookup Functions
0
Cascading (Chained) Lookup Functions
0

Potential Omissions Number
Unused Variables
3
Supplementary Variables
0
Supplementary Variables Being Used
0
Overly Complex Variable Formulations (Richardson's Rule = 10)
0
Overly Complex Stock Formulations
0

Types:
L : Level (14 / 14) * SM : Smooth (0 / 0) * DE : Delay (15 / 15) * † LI : Level Initial (6) I : Initial (0)
C : Constant (25) F : Flow (33) A : Auxiliary (44) Sub: Subscripts (0) D : Data (0)
G : Game (0) T : Lookup (0 / 0) ††      
* (state variables / total stocks)
* * Feature not yet implemented.
† Total stocks do not include fixed delay variables.
†† (lookup variables / lookup tables).
 
Groups:
CMV USA (94)
(Default)
Control (4)
Simulation Control Parameters
Modules:
Default (98)
Views:
View 1 (173)View 2 (0) 

TOP View 1 (173 variables)
Module
Group
Type
Variable Name and Description
Default CMV USA
(Default)
F,A

becoming uninfectious (person/Year)
=
Infectious adults/duration of the infection
Present in 1 view: Used by:
Default CMV USA
(Default)
C
birth rate (1/Year)
= 0.0135
Present in 1 view:
Used by:
Default CMV USA
(Default)
A
chance of transmission seropositive (Dmnl)
= 0.014*(1-
Policy 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

children becoming uninfectious (person/Year)
=
Infectious children/duration of the infection
Present in 1 view: Used by:
Default CMV USA
(Default)
A
children contact rate (contact/(person*Year))
= 40*(1-
Policy 4)
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Children with CMV-induced Mental Retardation (person)
=
MR after primary infection in T1+MR after primary infection in T2+MR after seropositive transmission-severely disabled death dt + [initial value MR children]
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Children with CMV-induced SNHL aged 2 (person)
=
SNHL after infection in T1+SNHL after infection in T2+SNHL after seropositive transmission-growth SNHL children dt + [initial value SNHL children]
Present in 1 view: Used by:
Default CMV USA
(Default)
A
contact rate among pregnant women (contact/(person*Year))
= 40*(1-
Policy 1)
Present in 1 view: Used by:
Default CMV USA
(Default)
A
Disabled children due to CMV (person)
=
Children with CMV-induced Mental Retardation+Children with CMV-induced SNHL aged 2
Present in 1 view:
Default CMV USA
(Default)
C
duration of infancy (Year)
= 1.5
Present in 1 view:
Used by:
Default CMV USA
(Default)
C
duration of the infection (Year)
= 1.5
Present in 1 view:
Used by:
Default CMV USA
(Default)
A
fatality ratio of symptomatic infant (Dmnl)
= 0.07*(1+
Policy 3.1)
Present in 1 view: Used by:
Default CMV USA
(Default)
A
fraction of CMV-induced disabled children (Dmnl)
= (
Children with CMV-induced SNHL aged 2+Children with CMV-induced Mental Retardation)/(Children with CMV-induced SNHL aged 2+Children with CMV-induced Mental Retardation+Infectious healthy children aged 2+Non infected children aged 2)
Present in 1 view:
Default CMV USA
(Default)
F,A

growth (person/Year)
=
Non infected children/growth time
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

growth infectious children (person/Year)
=
Infectious healthy children aged 2/duration of infancy
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
growth non infected between 2 and 3.5 (person/Year)
= DELAY N(
non infected after T1+non infected after T2+healthy from seronegative deliveries+non infected from seropositive mothers, duration of infancy, MAX(non infected after T1+non infected after T2+healthy from seronegative deliveries+non infected from seropositive mothers-(Non infected children aged 2*risk of acquiring infection in children), 0), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

growth SNHL children (person/Year)
=
Children with CMV-induced SNHL aged 2/duration of infancy
Present in 1 view: Used by:
Default CMV USA
(Default)
C
growth time (Year)
= 15
Present in 1 view:
Used by:
Default CMV USA
(Default)
F,A

growth with cmv (person/Year)
=
Non infectious seropositive children/growth time
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
healthy from seronegative deliveries (person/Year)
= DELAY N(
seronegative deliveries, 2, seronegative deliveries, 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
A
Infected children (person)
=
Children with CMV-induced Mental Retardation+Infectious healthy children aged 2+Children with CMV-induced SNHL aged 2
Present in 1 view:
Default CMV USA
(Default)
A
infected fraction of the population (Dmnl)
= (
Children with CMV-induced Mental Retardation+Children with CMV-induced SNHL aged 2+Infectious adults+Infectious healthy children aged 2)/total population
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

infections in adults (person/Year)
=
Seronegative adults*risk of acquiring infection in adults
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

infections in children (person/Year)
=
Non infected children*risk of acquiring infection in children
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Infectious adults (person)
=
infections in adults-becoming uninfectious dt + [1.5e+006]
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
infectious after seropositive transmission (person/Year)
= DELAY N(
Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of symptomatic seropositive that shows CNS signs)/(3*trimester)+(1-percentage of primary symptomatic infant)*(1-percentage of asymptomatic seropositive that shows CNS signs)/(3*trimester)), 2, Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)/(3*trimester)), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
infectious after T1 (person/Year)
= DELAY N(
primary infections T1*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of symptomatic after T1 that shows CNS signs)+(1-percentage of primary symptomatic infant)*(1-percentage of asymptomatic after T1 that shows signs of CNS)), 2.5, primary infections T1*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
infectious after T2 (person/Year)
= DELAY N(
primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of infant T2 that shows CNS signs)+(1-percentage of primary symptomatic infant)*(1-percentage of infant T2 that shows CNS signs)), 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Infectious children (person)
=
growth infectious children+growth SNHL children+infections in children-children becoming uninfectious dt + [1.5e+006]
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Infectious healthy children aged 2 (person)
=
infectious after seropositive transmission+infectious after T1+infectious after T2-growth infectious children dt + [initial value infectious healthy children]
Present in 1 view: Used by:
Default CMV USA
(Default)
A
infectivity (person/contact)
= 0.04*(1-
Policy 5)
Present in 1 view: Used by:
Default CMV USA
(Default)
LI,C
initial value infectious healthy children (person)
= 32000
Present in 1 view:
Used by:
Default CMV USA
(Default)
LI,C
initial value MR children (person)
= 3500
Present in 1 view:
Used by:
Default CMV USA
(Default)
LI,C
initial value non infected children (person)
= 360000
Present in 1 view:
Used by:
Default CMV USA
(Default)
LI,C
initial value seronegative pregnancies T1 (person)
= 50000
Present in 1 view:
Used by:
Default CMV USA
(Default)
LI,C
initial value seropositive pregnancies (person)
= 50000
Present in 1 view:
Used by:
Default CMV USA
(Default)
LI,C
initial value SNHL children (person)
= 6000
Present in 1 view:
Used by:
Default CMV USA
(Default)
A
inter adult contact rate (contact/(Year*person))
= 40*(1-
Policy 4)
Present in 1 view: Used by:
Default CMV USA
(Default)
C
life expectancy (Year)
= 60
Present in 1 view:
Used by:
Default CMV USA
(Default)
DE,F
MR after primary infection in T1 (person/Year)
= DELAY N(
primary infections T1*transmission rate after primary infection*(percentage of primary symptomatic infant*(1-fatality ratio of symptomatic infant)*percentage of symptomatic after T1 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic after T1 that shows signs of CNS)*percentage of CNS that leads to serious MR, 2.5, primary infections T1*transmission rate after primary infection*(1-fatality ratio of symptomatic infant), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
MR after primary infection in T2 (person/Year)
= DELAY N(
primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of infant T2 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of infant T2 that shows CNS signs)*percentage of CNS that leads to serious MR, 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
MR after seropositive transmission (person/Year)
= DELAY N(
Pregnancies of seropositive mothers*chance of transmission seropositive*(percentage of primary symptomatic infant*(1-fatality ratio of symptomatic infant)*percentage of symptomatic seropositive that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic seropositive that shows CNS signs)*percentage of CNS that leads to serious MR/(3*trimester), 2, Pregnancies of seropositive mothers*chance of transmission seropositive/(3*trimester), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
C
multiple birth coefficient (Dmnl)
= 1.04
Present in 1 view:
Used by:
Default CMV USA
(Default)
F,A

non infected 2nd T (person/Year)
=
Seronegative pregnancies T1*((1/trimester)-risk of acquiring infection in pregnancy)
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
non infected after T1 (person/Year)
= DELAY N(
primary infections T1*(1-transmission rate after primary infection), 2.5, primary infections T1*(1-transmission rate after primary infection), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
non infected after T2 (person/Year)
= DELAY N(
primary infections T2*(1-transmission rate after primary infection), 2.25, primary infections T2*(1-transmission rate after primary infection), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Non infected children (person)
=
growth non infected between 2 and 3.5-growth-infections in children dt + [1.5e+007]
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Non infected children aged 2 (person)
=
healthy from seronegative deliveries+non infected after T1+non infected after T2+non infected from seropositive mothers-growth non infected between 2 and 3.5 dt + [initial value non infected children]
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
non infected from seropositive mothers (person/Year)
= DELAY N(
Pregnancies of seropositive mothers*(1-chance of transmission seropositive)/(3*trimester), 2, Pregnancies of seropositive mothers*(1-chance of transmission seropositive)/(3*trimester), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

non infected T3 (person/Year)
=
Seronegative pregnancies T2*((1/trimester)-risk of acquiring infection in pregnancy)
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Non infectious seropositive adults (person)
=
becoming uninfectious+growth with cmv-seropositive adult death dt + [2e+008]
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Non infectious seropositive children (person)
=
children becoming uninfectious-growth with cmv dt + [1.5e+007]
Present in 1 view: Used by:
Default CMV USA
(Default)
A
percentage of asymptomatic after T1 that shows signs of CNS (Dmnl)
= 0.5*(1-
Policy 3.2)
Present in 1 view: Used by:
Default CMV USA
(Default)
C
percentage of asymptomatic seropositive that shows CNS signs (Dmnl)
= 0.1
Present in 1 view:
Used by:
Default CMV USA
(Default)
C
percentage of CNS that leads to serious MR (Dmnl)
= 0.25
Present in 1 view:
Used by:
Default CMV USA
(Default)
A
percentage of infant T2 that shows CNS signs (Dmnl)
= 0.08*(1-
Policy 3.2)
Present in 1 view: Used by:
Default CMV USA
(Default)
C
percentage of primary symptomatic infant (Dmnl)
= 0.18
Present in 1 view:
Used by:
Default CMV USA
(Default)
A
percentage of symptomatic after T1 that shows CNS signs (Dmnl)
= 0.8*(1-
Policy 3.2)
Present in 1 view: Used by:
Default CMV USA
(Default)
C
percentage of symptomatic seropositive that shows CNS signs (Dmnl)
= 0.5
Present in 1 view:
Used by:
Default CMV USA
(Default)
A
Policy 1 (contact/(person*Year))
= 0.5*
switch 1
Present in 1 view: Used by:
Default CMV USA
(Default)
A
Policy 2 (Dmnl)
= 0.2*
switch 2
Present in 1 view: Used by:
Default CMV USA
(Default)
A
Policy 3.1 (Dmnl)
= 1*
switch 3.1
Present in 1 view: Used by:
Default CMV USA
(Default)
A
Policy 3.2 (Dmnl)
= 0.4*
switch 3 2
Present in 1 view: Used by:
Default CMV USA
(Default)
A
Policy 4 (contact/(person*Year))
= 0.2*
switch 4
Present in 1 view: Used by:
Default CMV USA
(Default)
A
Policy 5 (person/contact)
= 0.5*
switch 5
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Pregnancies of seropositive mothers (person)
=
seropositive pregnancies-seropositive deliveries dt + [initial value seropositive pregnancies]
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

primary infections T1 (person/Year)
=
Seronegative pregnancies T1*risk of acquiring infection in pregnancy
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

primary infections T2 (person/Year)
=
Seronegative pregnancies T2*risk of acquiring infection in pregnancy
Present in 1 view: Used by:
Default CMV USA
(Default)
A
risk of acquiring infection in adults (1/Year)
=
infected fraction of the population*infectivity*inter adult contact rate
Present in 1 view: Used by:
Default CMV USA
(Default)
A
risk of acquiring infection in children (1/Year)
=
infectivity*infected fraction of the population*children contact rate
Present in 1 view: Used by:
Default CMV USA
(Default)
A
risk of acquiring infection in pregnancy (1/Year)
=
infectivity*infected fraction of the population*contact rate among pregnant women
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
seronegative adult death (person/Year)
= DELAY N(
growth, life expectancy, MAX(growth -(Seronegative adults*risk of acquiring infection in adults), 0), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Seronegative adults (person)
=
growth-infections in adults-seronegative adult death dt + [1e+008]
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

seronegative deliveries (person/Year)
=
Seronegative pregnancies T3/trimester
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

seronegative pregnancies (person/Year)
=
birth rate*multiple birth coefficient*Seronegative adults
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Seronegative pregnancies T1 (person)
=
seronegative pregnancies-non infected 2nd T-primary infections T1 dt + [initial value seronegative pregnancies T1]
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Seronegative pregnancies T2 (person)
=
non infected 2nd T-non infected T3-primary infections T2 dt + [0]
Present in 1 view: Used by:
Default CMV USA
(Default)
L
Seronegative pregnancies T3 (person)
=
non infected T3-seronegative deliveries dt + [0]
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

seropositive adult death (person/Year)
=
Non infectious seropositive adults/life expectancy
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

seropositive deliveries (person/Year)
=
Pregnancies of seropositive mothers/(3*trimester)
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

seropositive pregnancies (person/Year)
= (
Infectious adults+Non infectious seropositive adults)*birth rate*multiple birth coefficient
Present in 1 view: Used by:
Default CMV USA
(Default)
F,A

severely disabled death (person/Year)
=
Children with CMV-induced Mental Retardation/duration of infancy
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
SNHL after infection in T1 (person/Year)
= DELAY N(
primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of symptomatic after T1 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic after T1 that shows signs of CNS)*(1-percentage of CNS that leads to serious MR), 2.5, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
SNHL after infection in T2 (person/Year)
= DELAY N(
primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of infant T2 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of infant T2 that shows CNS signs)*(1-percentage of CNS that leads to serious MR), 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
DE,F
SNHL after seropositive transmission (person/Year)
= DELAY N(
Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of symptomatic seropositive that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic seropositive that shows CNS signs)*(1-percentage of CNS that leads to serious MR)/(3*trimester), 2, Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant))/(3*trimester), 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
C
switch 1 (contact/(person*Year))
= 0
Present in 1 view:
Used by:
Default CMV USA
(Default)
C
switch 2 (Dmnl)
= 0
Present in 1 view:
Used by:
Default CMV USA
(Default)
C
switch 3 2 (Dmnl)
= 0
Present in 1 view:
Used by:
Default CMV USA
(Default)
C
switch 3.1 (Dmnl)
= 0
Present in 1 view:
Used by:
Default CMV USA
(Default)
C
switch 4 (contact/(person*Year))
= 0
Present in 1 view:
Used by:
Default CMV USA
(Default)
C
switch 5 (person/contact)
= 0
Present in 1 view:
Used by:
Default CMV USA
(Default)
A
total population (person)
=
Infectious healthy children aged 2+Non infectious seropositive children+Children with CMV-induced SNHL aged 2+Non infected children aged 2+Infectious adults+Non infectious seropositive adults+Seronegative adults+Infectious children+Non infected children
Present in 1 view: Used by:
Default CMV USA
(Default)
A
transmission rate after primary infection (Dmnl)
= 0.35*(1-
Policy 2)
Present in 1 view: Used by:
Default CMV USA
(Default)
A
trimester (Year)
= 3/12
Present in 1 view:
Used by:
TOP View 2 (0 variables)
Module
Group
Type
Variable Name and Description


List of 94 Undocumented Variables

Module
Group
Type
Variable (94)
Default CMV USA F,A becoming uninfectious (person/Year)
Default CMV USA C birth rate (1/Year)
Default CMV USA A chance of transmission seropositive (Dmnl)
Default CMV USA F,A children becoming uninfectious (person/Year)
Default CMV USA A children contact rate (contact/(person*Year))
Default CMV USA L Children with CMV-induced Mental Retardation (person)
Default CMV USA L Children with CMV-induced SNHL aged 2 (person)
Default CMV USA A contact rate among pregnant women (contact/(person*Year))
Default CMV USA A Disabled children due to CMV (person)
Default CMV USA C duration of infancy (Year)
Default CMV USA C duration of the infection (Year)
Default CMV USA A fatality ratio of symptomatic infant (Dmnl)
Default CMV USA A fraction of CMV-induced disabled children (Dmnl)
Default CMV USA F,A growth (person/Year)
Default CMV USA F,A growth infectious children (person/Year)
Default CMV USA DE,F growth non infected between 2 and 3.5 (person/Year)
Default CMV USA F,A growth SNHL children (person/Year)
Default CMV USA C growth time (Year)
Default CMV USA F,A growth with cmv (person/Year)
Default CMV USA DE,F healthy from seronegative deliveries (person/Year)
Default CMV USA A Infected children (person)
Default CMV USA A infected fraction of the population (Dmnl)
Default CMV USA F,A infections in adults (person/Year)
Default CMV USA F,A infections in children (person/Year)
Default CMV USA L Infectious adults (person)
Default CMV USA DE,F infectious after seropositive transmission (person/Year)
Default CMV USA DE,F infectious after T1 (person/Year)
Default CMV USA DE,F infectious after T2 (person/Year)
Default CMV USA L Infectious children (person)
Default CMV USA L Infectious healthy children aged 2 (person)
Default CMV USA A infectivity (person/contact)
Default CMV USA LI,C initial value infectious healthy children (person)
Default CMV USA LI,C initial value MR children (person)
Default CMV USA LI,C initial value non infected children (person)
Default CMV USA LI,C initial value seronegative pregnancies T1 (person)
Default CMV USA LI,C initial value seropositive pregnancies (person)
Default CMV USA LI,C initial value SNHL children (person)
Default CMV USA A inter adult contact rate (contact/(Year*person))
Default CMV USA C life expectancy (Year)
Default CMV USA DE,F MR after primary infection in T1 (person/Year)
Default CMV USA DE,F MR after primary infection in T2 (person/Year)
Default CMV USA DE,F MR after seropositive transmission (person/Year)
Default CMV USA C multiple birth coefficient (Dmnl)
Default CMV USA F,A non infected 2nd T (person/Year)
Default CMV USA DE,F non infected after T1 (person/Year)
Default CMV USA DE,F non infected after T2 (person/Year)
Default CMV USA L Non infected children (person)
Default CMV USA L Non infected children aged 2 (person)
Default CMV USA DE,F non infected from seropositive mothers (person/Year)
Default CMV USA F,A non infected T3 (person/Year)
Default CMV USA L Non infectious seropositive adults (person)
Default CMV USA L Non infectious seropositive children (person)
Default CMV USA A percentage of asymptomatic after T1 that shows signs of CNS (Dmnl)
Default CMV USA C percentage of asymptomatic seropositive that shows CNS signs (Dmnl)
Default CMV USA C percentage of CNS that leads to serious MR (Dmnl)
Default CMV USA A percentage of infant T2 that shows CNS signs (Dmnl)
Default CMV USA C percentage of primary symptomatic infant (Dmnl)
Default CMV USA A percentage of symptomatic after T1 that shows CNS signs (Dmnl)
Default CMV USA C percentage of symptomatic seropositive that shows CNS signs (Dmnl)
Default CMV USA A Policy 1 (contact/(person*Year))
Default CMV USA A Policy 2 (Dmnl)
Default CMV USA A Policy 3.1 (Dmnl)
Default CMV USA A Policy 3.2 (Dmnl)
Default CMV USA A Policy 4 (contact/(person*Year))
Default CMV USA A Policy 5 (person/contact)
Default CMV USA L Pregnancies of seropositive mothers (person)
Default CMV USA F,A primary infections T1 (person/Year)
Default CMV USA F,A primary infections T2 (person/Year)
Default CMV USA A risk of acquiring infection in adults (1/Year)
Default CMV USA A risk of acquiring infection in children (1/Year)
Default CMV USA A risk of acquiring infection in pregnancy (1/Year)
Default CMV USA DE,F seronegative adult death (person/Year)
Default CMV USA L Seronegative adults (person)
Default CMV USA F,A seronegative deliveries (person/Year)
Default CMV USA F,A seronegative pregnancies (person/Year)
Default CMV USA L Seronegative pregnancies T1 (person)
Default CMV USA L Seronegative pregnancies T2 (person)
Default CMV USA L Seronegative pregnancies T3 (person)
Default CMV USA F,A seropositive adult death (person/Year)
Default CMV USA F,A seropositive deliveries (person/Year)
Default CMV USA F,A seropositive pregnancies (person/Year)
Default CMV USA F,A severely disabled death (person/Year)
Default CMV USA DE,F SNHL after infection in T1 (person/Year)
Default CMV USA DE,F SNHL after infection in T2 (person/Year)
Default CMV USA DE,F SNHL after seropositive transmission (person/Year)
Default CMV USA C switch 1 (contact/(person*Year))
Default CMV USA C switch 2 (Dmnl)
Default CMV USA C switch 3 2 (Dmnl)
Default CMV USA C switch 3.1 (Dmnl)
Default CMV USA C switch 4 (contact/(person*Year))
Default CMV USA C switch 5 (person/contact)
Default CMV USA A total population (person)
Default CMV USA A transmission rate after primary infection (Dmnl)
Default CMV USA A trimester (Year)

List of 43 Equations with Embedded Data

Module
Group
Type
Variable (43)
Default CMV USA A chance of transmission seropositive (Dmnl)
Default CMV USA A children contact rate (contact/(person*Year))
Default CMV USA A contact rate among pregnant women (contact/(person*Year))
Default CMV USA A fatality ratio of symptomatic infant (Dmnl)
Default CMV USA DE,F growth non infected between 2 and 3.5 (person/Year)
Default CMV USA DE,F healthy from seronegative deliveries (person/Year)
Default CMV USA L Infectious adults (person)
Default CMV USA DE,F infectious after seropositive transmission (person/Year)
Default CMV USA DE,F infectious after T1 (person/Year)
Default CMV USA DE,F infectious after T2 (person/Year)
Default CMV USA L Infectious children (person)
Default CMV USA A infectivity (person/contact)
Default CMV USA A inter adult contact rate (contact/(Year*person))
Default CMV USA DE,F MR after primary infection in T1 (person/Year)
Default CMV USA DE,F MR after primary infection in T2 (person/Year)
Default CMV USA DE,F MR after seropositive transmission (person/Year)
Default CMV USA F,A non infected 2nd T (person/Year)
Default CMV USA DE,F non infected after T1 (person/Year)
Default CMV USA DE,F non infected after T2 (person/Year)
Default CMV USA L Non infected children (person)
Default CMV USA DE,F non infected from seropositive mothers (person/Year)
Default CMV USA F,A non infected T3 (person/Year)
Default CMV USA L Non infectious seropositive adults (person)
Default CMV USA L Non infectious seropositive children (person)
Default CMV USA A percentage of asymptomatic after T1 that shows signs of CNS (Dmnl)
Default CMV USA A percentage of infant T2 that shows CNS signs (Dmnl)
Default CMV USA A percentage of symptomatic after T1 that shows CNS signs (Dmnl)
Default CMV USA A Policy 1 (contact/(person*Year))
Default CMV USA A Policy 2 (Dmnl)
Default CMV USA A Policy 3.1 (Dmnl)
Default CMV USA A Policy 3.2 (Dmnl)
Default CMV USA A Policy 4 (contact/(person*Year))
Default CMV USA A Policy 5 (person/contact)
Default CMV USA DE,F seronegative adult death (person/Year)
Default CMV USA L Seronegative adults (person)
Default CMV USA L Seronegative pregnancies T2 (person)
Default CMV USA L Seronegative pregnancies T3 (person)
Default CMV USA F,A seropositive deliveries (person/Year)
Default CMV USA DE,F SNHL after infection in T1 (person/Year)
Default CMV USA DE,F SNHL after infection in T2 (person/Year)
Default CMV USA DE,F SNHL after seropositive transmission (person/Year)
Default CMV USA A transmission rate after primary infection (Dmnl)
Default CMV USA A trimester (Year)

List of 29 State Variables

Module
Group
Type
Variable
Default CMV USA L Children with CMV-induced Mental Retardation (person)
Default CMV USA L Children with CMV-induced SNHL aged 2 (person)
Default CMV USA DE,F growth non infected between 2 and 3.5 (person/Year)
Default CMV USA DE,F healthy from seronegative deliveries (person/Year)
Default CMV USA L Infectious adults (person)
Default CMV USA DE,F infectious after seropositive transmission (person/Year)
Default CMV USA DE,F infectious after T1 (person/Year)
Default CMV USA DE,F infectious after T2 (person/Year)
Default CMV USA L Infectious children (person)
Default CMV USA L Infectious healthy children aged 2 (person)
Default CMV USA DE,F MR after primary infection in T1 (person/Year)
Default CMV USA DE,F MR after primary infection in T2 (person/Year)
Default CMV USA DE,F MR after seropositive transmission (person/Year)
Default CMV USA DE,F non infected after T1 (person/Year)
Default CMV USA DE,F non infected after T2 (person/Year)
Default CMV USA L Non infected children (person)
Default CMV USA L Non infected children aged 2 (person)
Default CMV USA DE,F non infected from seropositive mothers (person/Year)
Default CMV USA L Non infectious seropositive adults (person)
Default CMV USA L Non infectious seropositive children (person)
Default CMV USA L Pregnancies of seropositive mothers (person)
Default CMV USA DE,F seronegative adult death (person/Year)
Default CMV USA L Seronegative adults (person)
Default CMV USA L Seronegative pregnancies T1 (person)
Default CMV USA L Seronegative pregnancies T2 (person)
Default CMV USA L Seronegative pregnancies T3 (person)
Default CMV USA DE,F SNHL after infection in T1 (person/Year)
Default CMV USA DE,F SNHL after infection in T2 (person/Year)
Default CMV USA DE,F SNHL after seropositive transmission (person/Year)

List of 3 Unused Variables

Module
Group
Type
Variable (3)
Default CMV USA A Disabled children due to CMV (person)
Default CMV USA A fraction of CMV-induced disabled children (Dmnl)
Default CMV USA A Infected children (person)

List of 1 Views and Their 99 Variables*

 
View 1
 
Total: 173 :Total
becoming uninfectious (in 1 view) X becoming uninfectious (in 1 view)
birth rate (in 1 view) X birth rate (in 1 view)
chance of transmission seropositive (in 1 view) X chance of transmission seropositive (in 1 view)
children becoming uninfectious (in 1 view) X children becoming uninfectious (in 1 view)
children contact rate (in 1 view) X children contact rate (in 1 view)
Children with CMV-induced Mental Retardation (in 1 view) X Children with CMV-induced Mental Retardation (in 1 view)
Children with CMV-induced SNHL aged 2 (in 1 view) X Children with CMV-induced SNHL aged 2 (in 1 view)
contact rate among pregnant women (in 1 view) X contact rate among pregnant women (in 1 view)
Disabled children due to CMV (in 1 view) X Disabled children due to CMV (in 1 view)
duration of infancy (in 1 view) X duration of infancy (in 1 view)
duration of the infection (in 1 view) X duration of the infection (in 1 view)
fatality ratio of symptomatic infant (in 1 view) X fatality ratio of symptomatic infant (in 1 view)
FINAL TIME (in 0 views)   FINAL TIME (in 0 views)
fraction of CMV-induced disabled children (in 1 view) X fraction of CMV-induced disabled children (in 1 view)
growth (in 1 view) X growth (in 1 view)
growth infectious children (in 1 view) X growth infectious children (in 1 view)
growth non infected between 2 and 3.5 (in 1 view) X growth non infected between 2 and 3.5 (in 1 view)
growth SNHL children (in 1 view) X growth SNHL children (in 1 view)
growth time (in 1 view) X growth time (in 1 view)
growth with cmv (in 1 view) X growth with cmv (in 1 view)
healthy from seronegative deliveries (in 1 view) X healthy from seronegative deliveries (in 1 view)
Infected children (in 1 view) X Infected children (in 1 view)
infected fraction of the population (in 1 view) X infected fraction of the population (in 1 view)
infections in adults (in 1 view) X infections in adults (in 1 view)
infections in children (in 1 view) X infections in children (in 1 view)
Infectious adults (in 1 view) X Infectious adults (in 1 view)
infectious after seropositive transmission (in 1 view) X infectious after seropositive transmission (in 1 view)
infectious after T1 (in 1 view) X infectious after T1 (in 1 view)
infectious after T2 (in 1 view) X infectious after T2 (in 1 view)
Infectious children (in 1 view) X Infectious children (in 1 view)
Infectious healthy children aged 2 (in 1 view) X Infectious healthy children aged 2 (in 1 view)
infectivity (in 1 view) X infectivity (in 1 view)
INITIAL TIME (in 0 views)   INITIAL TIME (in 0 views)
initial value infectious healthy children (in 1 view) X initial value infectious healthy children (in 1 view)
initial value MR children (in 1 view) X initial value MR children (in 1 view)
initial value non infected children (in 1 view) X initial value non infected children (in 1 view)
initial value seronegative pregnancies T1 (in 1 view) X initial value seronegative pregnancies T1 (in 1 view)
initial value seropositive pregnancies (in 1 view) X initial value seropositive pregnancies (in 1 view)
initial value SNHL children (in 1 view) X initial value SNHL children (in 1 view)
inter adult contact rate (in 1 view) X inter adult contact rate (in 1 view)
life expectancy (in 1 view) X life expectancy (in 1 view)
MR after primary infection in T1 (in 1 view) X MR after primary infection in T1 (in 1 view)
MR after primary infection in T2 (in 1 view) X MR after primary infection in T2 (in 1 view)
MR after seropositive transmission (in 1 view) X MR after seropositive transmission (in 1 view)
multiple birth coefficient (in 1 view) X multiple birth coefficient (in 1 view)
non infected 2nd T (in 1 view) X non infected 2nd T (in 1 view)
non infected after T1 (in 1 view) X non infected after T1 (in 1 view)
non infected after T2 (in 1 view) X non infected after T2 (in 1 view)
Non infected children (in 1 view) X Non infected children (in 1 view)
Non infected children aged 2 (in 1 view) X Non infected children aged 2 (in 1 view)
non infected from seropositive mothers (in 1 view) X non infected from seropositive mothers (in 1 view)
non infected T3 (in 1 view) X non infected T3 (in 1 view)
Non infectious seropositive adults (in 1 view) X Non infectious seropositive adults (in 1 view)
Non infectious seropositive children (in 1 view) X Non infectious seropositive children (in 1 view)
percentage of asymptomatic after T1 that shows signs of CNS (in 1 view) X percentage of asymptomatic after T1 that shows signs of CNS (in 1 view)
percentage of asymptomatic seropositive that shows CNS signs (in 1 view) X percentage of asymptomatic seropositive that shows CNS signs (in 1 view)
percentage of CNS that leads to serious MR (in 1 view) X percentage of CNS that leads to serious MR (in 1 view)
percentage of infant T2 that shows CNS signs (in 1 view) X percentage of infant T2 that shows CNS signs (in 1 view)
percentage of primary symptomatic infant (in 1 view) X percentage of primary symptomatic infant (in 1 view)
percentage of symptomatic after T1 that shows CNS signs (in 1 view) X percentage of symptomatic after T1 that shows CNS signs (in 1 view)
percentage of symptomatic seropositive that shows CNS signs (in 1 view) X percentage of symptomatic seropositive that shows CNS signs (in 1 view)
Policy 1 (in 1 view) X Policy 1 (in 1 view)
Policy 2 (in 1 view) X Policy 2 (in 1 view)
Policy 3.1 (in 1 view) X Policy 3.1 (in 1 view)
Policy 3.2 (in 1 view) X Policy 3.2 (in 1 view)
Policy 4 (in 1 view) X Policy 4 (in 1 view)
Policy 5 (in 1 view) X Policy 5 (in 1 view)
Pregnancies of seropositive mothers (in 1 view) X Pregnancies of seropositive mothers (in 1 view)
primary infections T1 (in 1 view) X primary infections T1 (in 1 view)
primary infections T2 (in 1 view) X primary infections T2 (in 1 view)
risk of acquiring infection in adults (in 1 view) X risk of acquiring infection in adults (in 1 view)
risk of acquiring infection in children (in 1 view) X risk of acquiring infection in children (in 1 view)
risk of acquiring infection in pregnancy (in 1 view) X risk of acquiring infection in pregnancy (in 1 view)
SAVEPER (in 0 views)   SAVEPER (in 0 views)
seronegative adult death (in 1 view) X seronegative adult death (in 1 view)
Seronegative adults (in 1 view) X Seronegative adults (in 1 view)
seronegative deliveries (in 1 view) X seronegative deliveries (in 1 view)
seronegative pregnancies (in 1 view) X seronegative pregnancies (in 1 view)
Seronegative pregnancies T1 (in 1 view) X Seronegative pregnancies T1 (in 1 view)
Seronegative pregnancies T2 (in 1 view) X Seronegative pregnancies T2 (in 1 view)
Seronegative pregnancies T3 (in 1 view) X Seronegative pregnancies T3 (in 1 view)
seropositive adult death (in 1 view) X seropositive adult death (in 1 view)
seropositive deliveries (in 1 view) X seropositive deliveries (in 1 view)
seropositive pregnancies (in 1 view) X seropositive pregnancies (in 1 view)
severely disabled death (in 1 view) X severely disabled death (in 1 view)
SNHL after infection in T1 (in 1 view) X SNHL after infection in T1 (in 1 view)
SNHL after infection in T2 (in 1 view) X SNHL after infection in T2 (in 1 view)
SNHL after seropositive transmission (in 1 view) X SNHL after seropositive transmission (in 1 view)
switch 1 (in 1 view) X switch 1 (in 1 view)
switch 2 (in 1 view) X switch 2 (in 1 view)
switch 3 2 (in 1 view) X switch 3 2 (in 1 view)
switch 3.1 (in 1 view) X switch 3.1 (in 1 view)
switch 4 (in 1 view) X switch 4 (in 1 view)
switch 5 (in 1 view) X switch 5 (in 1 view)
Time (in 1 view) X Time (in 1 view)
TIME STEP (in 0 views)   TIME STEP (in 0 views)
total population (in 1 view) X total population (in 1 view)
transmission rate after primary infection (in 1 view) X transmission rate after primary infection (in 1 view)
trimester (in 1 view) X trimester (in 1 view)
Total: 173 :Total
 
View 1
 

* Includes Time, if used in a view. Excludes variables not present in any view.


Level Structure †

"Children with CMV-induced Mental Retardation" = MR after primary infection in T1+MR after primary infection in T2+MR after seropositive transmission-severely disabled death dt + [initial value MR children]
initial value MR children = 3500
    MR after primary infection in T1 = DELAY N(primary infections T1*transmission rate after primary infection*(percentage of primary symptomatic infant*(1-fatality ratio of symptomatic infant)*percentage of symptomatic after T1 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic after T1 that shows signs of CNS)*percentage of CNS that leads to serious MR, 2.5, primary infections T1*transmission rate after primary infection*(1-fatality ratio of symptomatic infant), 2)
    MR after primary infection in T2 = DELAY N(primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of infant T2 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of infant T2 that shows CNS signs)*percentage of CNS that leads to serious MR, 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
    MR after seropositive transmission = DELAY N(Pregnancies of seropositive mothers*chance of transmission seropositive*(percentage of primary symptomatic infant*(1-fatality ratio of symptomatic infant)*percentage of symptomatic seropositive that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic seropositive that shows CNS signs)*percentage of CNS that leads to serious MR/(3*trimester), 2, Pregnancies of seropositive mothers*chance of transmission seropositive/(3*trimester), 2)
    severely disabled death = Children with CMV-induced Mental Retardation/duration of infancy

"Children with CMV-induced SNHL aged 2" = SNHL after infection in T1+SNHL after infection in T2+SNHL after seropositive transmission-growth SNHL children dt + [initial value SNHL children]
initial value SNHL children = 6000
    growth SNHL children = Children with CMV-induced SNHL aged 2/duration of infancy
    SNHL after infection in T1 = DELAY N(primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of symptomatic after T1 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic after T1 that shows signs of CNS)*(1-percentage of CNS that leads to serious MR), 2.5, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
    SNHL after infection in T2 = DELAY N(primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of infant T2 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of infant T2 that shows CNS signs)*(1-percentage of CNS that leads to serious MR), 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
    SNHL after seropositive transmission = DELAY N(Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of symptomatic seropositive that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic seropositive that shows CNS signs)*(1-percentage of CNS that leads to serious MR)/(3*trimester), 2, Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant))/(3*trimester), 2)

Infectious adults = infections in adults-becoming uninfectious dt + [1.5e+006]
    becoming uninfectious = Infectious adults/duration of the infection
    infections in adults = Seronegative adults*risk of acquiring infection in adults

Infectious children = growth infectious children+growth SNHL children+infections in children-children becoming uninfectious dt + [1.5e+006]
    children becoming uninfectious = Infectious children/duration of the infection
    growth infectious children = Infectious healthy children aged 2/duration of infancy
    infections in children = Non infected children*risk of acquiring infection in children

Infectious healthy children aged 2 = infectious after seropositive transmission+infectious after T1+infectious after T2-growth infectious children dt + [initial value infectious healthy children]
initial value infectious healthy children = 32000
    infectious after seropositive transmission = DELAY N( Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of symptomatic seropositive that shows CNS signs)/(3*trimester)+(1-percentage of primary symptomatic infant)*(1-percentage of asymptomatic seropositive that shows CNS signs)/(3*trimester)), 2, Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)/(3*trimester)), 2)
    infectious after T1 = DELAY N(primary infections T1*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of symptomatic after T1 that shows CNS signs)+(1-percentage of primary symptomatic infant)*(1-percentage of asymptomatic after T1 that shows signs of CNS)), 2.5, primary infections T1*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)
    infectious after T2 = DELAY N(primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of infant T2 that shows CNS signs)+(1-percentage of primary symptomatic infant)*(1-percentage of infant T2 that shows CNS signs)), 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2)

Non infected children = growth non infected between 2 and 3.5-growth-infections in children dt + [1.5e+007]
    growth = Non infected children/growth time
    "growth non infected between 2 and 3.5" = DELAY N(non infected after T1+non infected after T2+healthy from seronegative deliveries+non infected from seropositive mothers, duration of infancy, MAX(non infected after T1+non infected after T2+healthy from seronegative deliveries+non infected from seropositive mothers-(Non infected children aged 2*risk of acquiring infection in children), 0), 2)

Non infected children aged 2 = healthy from seronegative deliveries+non infected after T1+non infected after T2+non infected from seropositive mothers-growth non infected between 2 and 3.5 dt + [initial value non infected children]
initial value non infected children = 360000
    healthy from seronegative deliveries = DELAY N(seronegative deliveries, 2, seronegative deliveries, 2)
    non infected after T1 = DELAY N(primary infections T1*(1-transmission rate after primary infection), 2.5, primary infections T1*(1-transmission rate after primary infection), 2)
    non infected after T2 = DELAY N(primary infections T2*(1-transmission rate after primary infection), 2.25, primary infections T2*(1-transmission rate after primary infection), 2)
    non infected from seropositive mothers = DELAY N(Pregnancies of seropositive mothers*(1-chance of transmission seropositive)/(3*trimester), 2, Pregnancies of seropositive mothers*(1-chance of transmission seropositive)/(3*trimester), 2)

Non infectious seropositive adults = becoming uninfectious+growth with cmv-seropositive adult death dt + [2e+008]
    growth with cmv = Non infectious seropositive children/growth time
    seropositive adult death = Non infectious seropositive adults/life expectancy

Non infectious seropositive children = children becoming uninfectious-growth with cmv dt + [1.5e+007]

Pregnancies of seropositive mothers = seropositive pregnancies-seropositive deliveries dt + [initial value seropositive pregnancies]
initial value seropositive pregnancies = 50000
    seropositive deliveries = Pregnancies of seropositive mothers/(3*trimester)
    seropositive pregnancies = (Infectious adults+Non infectious seropositive adults)*birth rate*multiple birth coefficient

Seronegative adults = growth-infections in adults-seronegative adult death dt + [1e+008]
    seronegative adult death = DELAY N(growth, life expectancy, MAX(growth -(Seronegative adults*risk of acquiring infection in adults), 0), 2)

Seronegative pregnancies T1 = seronegative pregnancies-non infected 2nd T-primary infections T1 dt + [initial value seronegative pregnancies T1]
initial value seronegative pregnancies T1 = 50000
    non infected 2nd T = Seronegative pregnancies T1*((1/trimester)-risk of acquiring infection in pregnancy)
    primary infections T1 = Seronegative pregnancies T1*risk of acquiring infection in pregnancy
    seronegative pregnancies = birth rate*multiple birth coefficient*Seronegative adults

Seronegative pregnancies T2 = non infected 2nd T-non infected T3-primary infections T2 dt + [0]
    non infected T3 = Seronegative pregnancies T2*((1/trimester)-risk of acquiring infection in pregnancy)
    primary infections T2 = Seronegative pregnancies T2*risk of acquiring infection in pregnancy

Seronegative pregnancies T3 = non infected T3-seronegative deliveries dt + [0]
    seronegative deliveries = Seronegative pregnancies T3/trimester

†  Level Structure Report still under development.


Source file: CMV_USA.mdl (3-13-13 - 10:58 AM)
Report Created on 3-13-13 - 10:59 AM
SDM-Doc Tool Version 4.7.16
Decision and Information Sciences Division
Argonne National Laboratory